129 related articles for article (PubMed ID: 9123694)
1. Urologic manpower issues for the 21st century: assessing the impact of changing population demographics.
Weiner DM; McDaniel R; Lowe FC
Urology; 1997 Mar; 49(3):335-42. PubMed ID: 9123694
[TBL] [Abstract][Full Text] [Related]
2. American Urological Association survey of transurethral prostatectomy and the impact of changing medicare reimbursement.
Holtgrewe HL
Urol Clin North Am; 1990 Aug; 17(3):587-93. PubMed ID: 2197769
[TBL] [Abstract][Full Text] [Related]
3. [Demographic forecasts of medical workforce supply in France (2000-2050). What numerus clausus for what future?].
Doan BD; Lévy D; Pavot J
Cah Sociol Demogr Med; 2004; 44(1):101-48. PubMed ID: 15146660
[TBL] [Abstract][Full Text] [Related]
4. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
Yu X; Elliott SP; Wilt TJ; McBean AM
J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
[TBL] [Abstract][Full Text] [Related]
5. Prostates and profits: the social construction of benign prostatic hyperplasia in American men.
McDade T
Med Anthropol; 1996 May; 17(1):1-22. PubMed ID: 8757710
[TBL] [Abstract][Full Text] [Related]
6. Urologic diseases in America project: benign prostatic hyperplasia.
Wei JT; Calhoun E; Jacobsen SJ
J Urol; 2005 Apr; 173(4):1256-61. PubMed ID: 15758764
[TBL] [Abstract][Full Text] [Related]
7. 1999 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of incontinence and bladder cancer, and impact of managed care.
O'Leary MP; Gee WF; Holtgrewe HL; Blute ML; Cooper TP; Miles BJ; Nellans RE; Thomas R; Painter MR; Meyer JJ; Naslund MJ; Gormley EA; Blizzard R; Fenninger RB
J Urol; 2000 Oct; 164(4):1311-6. PubMed ID: 10992396
[TBL] [Abstract][Full Text] [Related]
8. Urological medical malpractice.
Kahan SE; Goldman HB; Marengo S; Resnick MI
J Urol; 2001 May; 165(5):1638-42. PubMed ID: 11342944
[TBL] [Abstract][Full Text] [Related]
9. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
[TBL] [Abstract][Full Text] [Related]
10. The natural history of benign prostatic hyperplasia.
Fitzpatrick JM
BJU Int; 2006 Apr; 97 Suppl 2():3-6; discussion 21-2. PubMed ID: 16507045
[TBL] [Abstract][Full Text] [Related]
11. The American Urological Association 2003 guideline on management of benign prostatic hyperplasia: a Canadian opinion.
Nickel JC; Saad F
Can J Urol; 2004 Apr; 11(2):2186-93. PubMed ID: 15182407
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
[TBL] [Abstract][Full Text] [Related]
13. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
[TBL] [Abstract][Full Text] [Related]
14. Otolaryngological manpower in Canada in the year 2000.
Ruby RR
J Otolaryngol; 1991 Oct; 20(5):305-9. PubMed ID: 1960783
[TBL] [Abstract][Full Text] [Related]
15. Geographic distribution of urologists throughout the United States using a county level approach.
Odisho AY; Fradet V; Cooperberg MR; Ahmad AE; Carroll PR
J Urol; 2009 Feb; 181(2):760-5; discussion 765-6. PubMed ID: 19091334
[TBL] [Abstract][Full Text] [Related]
16. Medical malpractice liability in clinical urology: a survey of practicing urologists.
Sobel DL; Loughlin KR; Coogan CL
J Urol; 2006 May; 175(5):1847-51. PubMed ID: 16600777
[TBL] [Abstract][Full Text] [Related]
17. Current and future need for academic urologists in the United States.
Lightfoot AJ; Rosevear HM; Steers WD; Tracy CR
J Urol; 2011 Jun; 185(6):2283-7. PubMed ID: 21497844
[TBL] [Abstract][Full Text] [Related]
18. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
Stovsky MD; Griffiths RI; Duff SB
J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
[TBL] [Abstract][Full Text] [Related]
19. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer.
Fawzy A; Fontenot C; Guthrie R; Baudier MM
Fam Med; 1997 May; 29(5):321-5. PubMed ID: 9165283
[TBL] [Abstract][Full Text] [Related]
20. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]